Abstract

Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient

Author(s): McElhiney Linda F

Issue: Mar/Apr 2010 - Compounding for Men

Page(s): 112-115

Download in electronic PDF format for $75
  • Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Page 1
  • Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Page 2
  • Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Page 3
  • Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient Page 4

Abstract

The first lung transplantation was performed successfully in 1983 and has become a viable option for end-stage pulmonary disease. Advances in surgical techniques, the development of better immunosuppressive agents, and the standardization of care have improved patient survival and quality of life. This article includes statistics on men versus women diagnosed with Chronic Obstructive Pulmonary Disease. Included with this article is a case report of a 52-year-old white male who had undergone a bilateral lung transplant. The patient’s medication protocol is discussed within this article, including the use of inhaled cyclosporine to treat acute cellular rejection, one of the major complications associated with lung transplantation. The formulation for the cyclosporine for aerosol that was prepared by a compounding pharmacist is included with this article.

Related Keywords

  • inhaled cyclosporin
  • lung transplantation
  • pulmonary disorders
  • chronic obstructive pulmonary disease
  • COPD
  • immunosuppressive agent
  • immunosuppressant
  • case report
  • formulation
  • aerosolization
  • adverse effects
  • inhalation therapy
  • aerosol

Related Categories

  • FORMULATIONS
  • CASE REPORTS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • RESPIRATION/LUNG/BREATHING

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2010
Pg. 112-115
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
Author(s): McElhiney Linda F
Jul/Aug 1997
Pg. 242-243
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Jan/Feb 2010
Pg. 40-45
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Jan/Feb 2012
Pg. 34-41
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Sep/Oct 2012
Pg. 364-368
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
Author(s): McNulty Jack P, Hahn Kristian
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Nov/Dec 2006
Pg. 405-408
Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Author(s): Davidson Gigi S
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Jan/Feb 2013
Pg. 24-27
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Author(s): Wung Deanna
May/Jun 2011
Pg. 194-199
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
Author(s): McElhiney Linda F
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jan/Feb 2017
Pg. 22-27
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Sep/Oct 2014
Pg. 370-377
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Mar/Apr 2017
Pg. 150-153
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Nov/Dec 2022
Pg. 468-472
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
May/Jun 2020
Pg. 242-245
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Author(s): Ngim Kenley, Patel Jalpa